"V体育官网" SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
- PMID: 33649297
- PMCID: PMC7919254
- DOI: 10.1038/s41420-021-00428-w (V体育平台登录)
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes (V体育官网)
Erratum in
-
Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. (V体育平台登录)Cell Death Discov. 2021 May 19;7(1):116. doi: 10.1038/s41420-021-00477-1. Cell Death Discov. 2021. PMID: 34011951 Free PMC article. No abstract available.
Abstract
Infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with leukopenia and uncontrolled inflammatory response in critically ill patients. A better comprehension of SARS-CoV-2-induced monocyte death is essential for the identification of therapies capable to control the hyper-inflammation and reduce viral replication in patients with 2019 coronavirus disease (COVID-19) VSports手机版. Here, we show that SARS-CoV-2 engages inflammasome and triggers pyroptosis in human monocytes, experimentally infected, and from patients under intensive care. Pyroptosis associated with caspase-1 activation, IL-1ß production, gasdermin D cleavage, and enhanced pro-inflammatory cytokine levels in human primary monocytes. At least in part, our results originally describe mechanisms by which monocytes, a central cellular component recruited from peripheral blood to respiratory tract, succumb to control severe COVID-19. .
Conflict of interest statement
The authors declare no competing interests.
Figures (V体育平台登录)





References
-
- Conti P, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies. J. Biol. Regul. Homeost. Agents. 2020;34:327–331. - PubMed
-
- Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020;38:1504–1507. - PMC (V体育官网) - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous